CM
EDIT icon

Caption Management’s Editas Medicine EDIT Stock Holding History

Caption Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-20,000
Closed -$68.2K – 1558
2024
Q3 		$68.2K Hold
20,000
– – ﹤0.01% 1151
2024
Q2 		$93.4K Buy
+20,000
New +$113K ﹤0.01% 1026
2023
Q3 		– Sell
-21,700
Closed -$179K – 1338
2023
Q2 		$179K Buy
21,700
+10,000
+85% +$87.1K ﹤0.01% 945
2023
Q1 		$84.8K Sell
11,700
-800
-6% -$7.11K ﹤0.01% 976
2022
Q4 		$111K Hold
12,500
– – ﹤0.01% 1125
2022
Q3 		$154K Buy
12,500
+8,500
+213% +$132K ﹤0.01% 1275
2022
Q2 		$47K Buy
+4,000
New +$53.6K ﹤0.01% 1342
2021
Q4 		– Sell
-45,000
Closed -$1.85M – 1677
2021
Q3 		$1.85M Buy
+45,000
New +$2.47M 0.02% 796
2021
Q2 		– Sell
-10,000
Closed -$369K – 1370
2021
Q1 		$420K Buy
+10,000
New +$570K 0.01% 844

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Caption Management's EDIT Position: Q4 2024 in Review

Caption Management sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 20,000 shares — an estimated $68.2K sold.

Caption Management first reported a position in EDIT in Q1 2021 and held it in 9 quarters. The position peaked at $1.85M in Q3 2021. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Caption Management reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Caption Management sold 20,000 Editas Medicine shares in Q4 2024, an estimated $68.2K.
  • Caption Management first reported a position in Editas Medicine in Q1 2021 and held it in 9 quarters.
  • Caption Management's Editas Medicine position peaked at $1.85M in Q3 2021.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Caption Management's 13F filing for Q4 2024, filed 14 Feb 2025.